Hostname: page-component-cb9f654ff-p5m67 Total loading time: 0 Render date: 2025-08-31T02:16:00.539Z Has data issue: false hasContentIssue false
  • English
  • Français

Hypertrophic cardiomyopathy in Duchenne muscular dystrophy: a case series

Published online by Cambridge University Press:  13 November 2024

Eleanor Greiner Open the ORCID record for Eleanor Greiner [Opens in a new window] ,
Nobuyuki Ikeda ,
Thomas D. Ryan Open the ORCID record for Thomas D. Ryan [Opens in a new window]  and
Chet R. Villa
Eleanor Greiner
Affiliation:
The Heart Institute, Cincinnati Children’s Hospital Medical Center, Department of Pediatrics, University of Cincinnati, Cincinnati, OH, USA
Nobuyuki Ikeda
Affiliation:
The Heart Institute, Cincinnati Children’s Hospital Medical Center, Department of Pediatrics, University of Cincinnati, Cincinnati, OH, USA
Thomas D. Ryan
Affiliation:
The Heart Institute, Cincinnati Children’s Hospital Medical Center, Department of Pediatrics, University of Cincinnati, Cincinnati, OH, USA
Chet R. Villa*
Affiliation:
The Heart Institute, Cincinnati Children’s Hospital Medical Center, Department of Pediatrics, University of Cincinnati, Cincinnati, OH, USA
*
Corresponding author: Chet R. Villa; Email: Chet.villa@cchmc.org
Get access Rights & Permissions [Opens in a new window]

Abstract

Duchenne muscular dystrophy is characterised by fibrofatty replacement of muscle, resulting in dilated cardiomyopathy. Hypertrophic cardiomyopathy affects 1:200–1:500 people and is characterised by asymmetric ventricular septal hypertrophy. To date, there have been two separately reported cases describing the combined pathology of these disorders. Herein, we expand upon these reports with a case series describing longitudinal findings in three patients with Duchenne muscular dystrophy who developed hypertrophic cardiomyopathy.

Keywords

Cardiomyopathymuscular dystrophyhypertrophy

Information

Type
Brief Report
Information
Cardiology in the Young , Volume 34 , Issue 10 , October 2024 , pp. 2272 - 2274
Check for updates
Copyright
© The Author(s), 2024. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

James, KA, Gralla, J, Ridall, LA et al. Left ventricular dysfunction in Duchenne muscular Dystrophy. Cardiol Young 2020; 30: 171–176.CrossRefGoogle ScholarPubMed
Marstrand, P, Han, L, Day, SM et al. Hypertrophic cardiomyopathy with left ventricular systolic dysfunction: insights from the SHaRe registry. Circulation 2020; 141: 1371–1383.CrossRefGoogle ScholarPubMed
Tandon, A, Taylor, MD, Cripe, LH. Co-occurring duchenne muscular dystrophy and hypertrophic cardiomyopathy in an adult with atypical cardiac phenotype. Cardiol Young 2015; 25: 355–357.CrossRefGoogle Scholar
Aspit, L, Arwas, N, Krymko, H, Etzion, Y, Parvari, R, Levitas, A. Duchenne muscular dystrophy and early onset hypertrophic cardiomyopathy associated with mutations in dystrophin and hypertrophic cardiomyopathy-associated genes. J Pediatr Genet 2022; 11: 304–308.CrossRefGoogle ScholarPubMed
Maron, BJ, Olivotto, I, Spirito, P et al. Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation 2000; 102: 858–864.CrossRefGoogle Scholar
O’Mahony, C, Elliott, P, McKenna, W. Sudden cardiac death in hypertrophic cardiomyopathy. Circ Arrhythm Electrophysiol 2013; 6: 443–451.CrossRefGoogle ScholarPubMed
Ommen, SR, Mital, S, Burke, MA et al. AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice guidelines. J Am Coll Cardiol 2020; 76: e159–e240.CrossRefGoogle Scholar
Semsarian, C, Ingles, J, Maron, MS, Maron, BJ. New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol 2015; 65: 1249–1254.CrossRefGoogle ScholarPubMed
Longo, DL, Maron, BJ. Clinical course and management of hypertrophic cardiomyopathy. N Engl J Med 2018; 379: 655–668.Google Scholar